BioCentury | May 7, 2012
Financial News

Allon completes private placement of units

...40 million Price: C$0.25 (unit) Shares after offering: 116.2 million Placement agent: Bloom Burton Investors: Neuro Discovery...
BioCentury | Jan 2, 2012
Financial News

Allon completes private placement of common stock and warrants

...Shares: 4.3 million Price: C$0.25 Shares after offering: 100.6 million Placement agent: GMP Securities Investor: Neuro Discovery...
BioCentury | Aug 27, 2007
Finance

Ebb & Flow

...in 1995, Neuromed now has raised $126 million. Existing investors MPM; James Richardson & Sons; Neuro Discovery...
BioCentury | Aug 22, 2007
Top Story

Neuromed raises $53.3 million

...$53.3 million in a series E round. Existing investors MPM Capital; James Richardson & Sons; Neuro Discovery...
BioCentury | Mar 9, 2006
Financial News

Neuromed raises $25 million

...Neuromed (Vancouver, B.C.) raised $25 million in a series D round. Existing investors MPM Capital; Neuro Discovery...
BioCentury | Feb 16, 2004
Finance

Ebb & Flow

...impairment and Alzheimer's disease (AD). The company has raised $4 million in venture funding from Neuro Discovery...
BioCentury | Nov 10, 2003
Finance

Ebb & Flow

...raised $32 million in a series C round led by MPM Capital. Other investors included Neuro Discovery...
BioCentury | Nov 4, 2003
Financial News

NeuroMed raises $32 million

...in a series C round of venture financing led by MPM Capital. Other investors included Neuro Discovery...
BioCentury | Apr 14, 2003
Finance

Ebb & Flow

...week unchanged at SEK34 and a market cap of SEK312 million ($36 million). Fund watch Neuro Discovery...
BioCentury | Apr 8, 2003
Financial News

Canadian fund's C$21.5 million first close

Neuro Discovery (CDNX:NDI) raised C$21.5 million ($14.6 million) in a first close for its North American biotech fund. The fund - which has a target of C$30 million (US$20.4 million) - will invest 40% in publicly held...
Items per page:
1 - 10 of 10
BioCentury | May 7, 2012
Financial News

Allon completes private placement of units

...40 million Price: C$0.25 (unit) Shares after offering: 116.2 million Placement agent: Bloom Burton Investors: Neuro Discovery...
BioCentury | Jan 2, 2012
Financial News

Allon completes private placement of common stock and warrants

...Shares: 4.3 million Price: C$0.25 Shares after offering: 100.6 million Placement agent: GMP Securities Investor: Neuro Discovery...
BioCentury | Aug 27, 2007
Finance

Ebb & Flow

...in 1995, Neuromed now has raised $126 million. Existing investors MPM; James Richardson & Sons; Neuro Discovery...
BioCentury | Aug 22, 2007
Top Story

Neuromed raises $53.3 million

...$53.3 million in a series E round. Existing investors MPM Capital; James Richardson & Sons; Neuro Discovery...
BioCentury | Mar 9, 2006
Financial News

Neuromed raises $25 million

...Neuromed (Vancouver, B.C.) raised $25 million in a series D round. Existing investors MPM Capital; Neuro Discovery...
BioCentury | Feb 16, 2004
Finance

Ebb & Flow

...impairment and Alzheimer's disease (AD). The company has raised $4 million in venture funding from Neuro Discovery...
BioCentury | Nov 10, 2003
Finance

Ebb & Flow

...raised $32 million in a series C round led by MPM Capital. Other investors included Neuro Discovery...
BioCentury | Nov 4, 2003
Financial News

NeuroMed raises $32 million

...in a series C round of venture financing led by MPM Capital. Other investors included Neuro Discovery...
BioCentury | Apr 14, 2003
Finance

Ebb & Flow

...week unchanged at SEK34 and a market cap of SEK312 million ($36 million). Fund watch Neuro Discovery...
BioCentury | Apr 8, 2003
Financial News

Canadian fund's C$21.5 million first close

Neuro Discovery (CDNX:NDI) raised C$21.5 million ($14.6 million) in a first close for its North American biotech fund. The fund - which has a target of C$30 million (US$20.4 million) - will invest 40% in publicly held...
Items per page:
1 - 10 of 10